首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1325319

全球乳鐵蛋白市場 - 2023-2030

Global Lactoferrin Market - 2023-2030

出版日期: 2023年08月04日 | 出版商:

DataM Intelligence | 英文 102 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球乳鐵蛋白市場在 2022 年達到 3.623 億美元，預計到 2030 年將實現利潤豐厚的成長，達到 6.413 億美元。在 2023-2030 年預測期內，該市場的年複合成長率為 7.4%。

消費者對膳食補充劑和具有特定健康益處的功能性食品的興趣正在上升。由於其具有增強免疫力、促進腸道健康和抗氧化特性，乳鐵蛋白被用於功能性食品和補充劑產品中。消費者預計會更頻繁地使用富含乳鐵蛋白的產品，因為他們正在尋找天然且實用的方法來增強整體健康和福祉。

例如，2023 年 3 月 17 日，FrieslandCampina Ingredients 在荷蘭費赫爾建造了一座新的乳鐵蛋白生產工廠，以幫助滿足全球嬰兒和成人營養行業不斷成長的需求。該工廠將公司的總產能從每年 20 噸提高到 80 噸。

市場動態

不斷成長的嬰兒人口正在推動乳鐵蛋白市場的成長

全球許多國家的出生率不斷上升，導致新生兒人口增加。由於人口擴張、醫療設施增加和社會經濟動態變化，出生率不斷上升。據聯合國統計，每天有 385,000 名新生兒出生。每年，這一金額超過 1.4 億美元。隨著越來越多的嬰兒出生，對嬰兒餵養產品的需求不斷增加，尤其是含有乳鐵蛋白的嬰兒餵養產品。

雖然母乳喂養被認為是嬰兒最健康的營養來源，但從母乳喂養轉向配方奶餵養的情況發生了重大轉變，尤其是在城市。這種趨勢可能歸因於多種因素，例如職業母親數量的增加、生活方式的改變和文化影響。因此，隨著越來越多的嬰兒依賴配方奶餵養，對嬰兒配方奶粉（尤其是富含乳鐵蛋白的配方奶粉）的需求也在成長。

人們對乳鐵蛋白健康益處的認知不斷提高正在推動乳鐵蛋白市場的成長

乳鐵蛋白因其增強免疫功能的潛力而受到認可。人們發現它通過支持淋巴細胞和自然殺傷細胞等免疫細胞的產生和活動對免疫系統產生積極影響。此外，乳鐵蛋白與鐵結合的能力可抑制細菌和病毒的生長，表現出抗菌特性。隨著人們對免疫健康的日益關注，乳鐵蛋白被認為是免疫支持補充劑和功能性食品的寶貴成分。

乳鐵蛋白在維持腸道健康方面發揮著重要作用。它通過促進雙歧桿菌和乳酸桿菌等有益細菌的生長，同時抑制有害細菌的生長，幫助調節腸道微生物群。乳鐵蛋白具有抗氧化活性，有助於對抗氧化壓力並降低與炎症相關的慢性疾病的風險。隨著人們越來越意識到炎症在各種健康狀況中的作用，乳鐵蛋白的抗炎功效有助於其市場成長。

監管和知識產權問題可能會阻礙乳鐵蛋白市場的成長

監管機構為含有乳鐵蛋白的食品和藥品製定了嚴格的安全和品質標準。遵守這些標准通常需要嚴格的測試、可追溯性和品質控制措施。滿足這些標準可能成本高昂且耗時，特別是對於可能缺乏必要資源和專業知識的小規模生產商而言。

專利和知識產權在乳鐵蛋白市場中發揮著至關重要的作用。知識產權保護對於投資乳鐵蛋白產品研發的製造商至關重要。然而，應對知識產權的複雜性可能具有挑戰性，而且專利糾紛可能會阻礙創新和市場成長。

COVID-19 影響分析

COVID-19 分析包括新冠疫情前情景、新冠疫情情景和新冠疫情后情景以及定價動態（包括與新冠疫情前情景相比的大流行期間和大流行後的價格變化）、供需譜（需求和供應變化）供應由於貿易限制、封鎖和後續問題）、政府舉措（政府機構振興市場、部門或行業的舉措）和製造商戰略舉措（此處將介紹製造商為緩解新冠疫情問題所做的努力）。

Market Overview

Global Lactoferrin Market reached US$ 362.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 641.3 million by 2030. The market is growing at a CAGR of 7.4% during the forecast period 2023-2030.

Consumer interest in dietary supplements and functional foods with specific health benefits is rising. Because of its immune-boosting, gut-health-promoting, and antioxidant properties, lactoferrin is used in functional food and supplement products. Customers are anticipated to use lactoferrin-enriched goods more frequently as they look for natural and practical ways to enhance their overall health and well-being.

For instance, On March 17, 2023, FrieslandCampina Ingredients built a new lactoferrin production plant in Veghel, Netherlands, to assist fulfill rising worldwide demand in the infant and adult nutrition industries. The facility boosts the company's total capacity from 20 to 80 metric tonnes per year.

Market Dynamics

The Rising Infant Population is Driving the Market Growth of Lactoferrin

The global birth rate has been increasing in many countries, resulting to an increase in the newborn population. Birth rates are rising as a result of population expansion, increased healthcare facilities, and altering socioeconomic dynamics. Every day, 385,000 newborns are born, according to the United Nations. Every year, this amounts to more than 140 million dollars. As more babies are born, there is an increased need for baby feeding products, particularly those containing lactoferrin.

While breastfeeding is thought to be the healthiest source of nutrition for babies, there is a significant shift away from breastfeeding and towards formula feeding, particularly in cities. This tendency may be attributed to a number of factors such as an increase in the number of working mothers, lifestyle changes, and cultural influences. As a result, as more babies rely on formula feeding, the need for baby formula options, particularly lactoferrin-enriched formula, grows.

Increased Awareness of Lactoferrin's Health Benefits is Driving Lactoferrin Market Growth

Lactoferrin is recognized for its potential in enhancing immune function. It has been found to have a positive impact on the immune system by supporting the production and activity of immune cells like lymphocytes and natural killer cells. Additionally, lactoferrin's ability to bind to iron inhibits the growth of bacteria and viruses, displaying antimicrobial properties. With growing concerns over immune health, lactoferrin is being recognized as a valuable ingredient for immune-supporting supplements and functional foods.

Lactoferrin plays a role in maintaining a healthy gut. It helps regulate the gut microbiota by promoting the growth of beneficial bacteria like bifidobacteria and lactobacilli while inhibiting the growth of harmful bacteria. Lactoferrin exhibits antioxidant activity, which helps combat oxidative stress and reduce the risk of chronic diseases associated with inflammation. As people become more conscious of the role of inflammation in various health conditions, lactoferrin's anti-inflammatory benefits contribute to its market growth.

Regulatory and Intellectual Property Issues can Hamper the Growth of the Lactoferrin Market

Regulatory authorities set stringent safety and quality standards for food and pharmaceutical products containing lactoferrin. Compliance with these standards often requires rigorous testing, traceability, and quality control measures. Meeting these standards can be costly and time-consuming, especially for small-scale producers who may lack the necessary resources and expertise.

Patents and intellectual property rights play a crucial role in the lactoferrin market. The protection of intellectual property is essential for manufacturers investing in the research and development of lactoferrin-based products. However, navigating the complexities of intellectual property rights can be challenging, and patent disputes can impede innovation and market growth.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global lactoferrin market is segmented based on source, application, end-use, and region.

Abundance of 2'-Fucosyllactose (2'FL) in Human Milk

In 2022, based on the source, bovine lactoferrin held the highest share of the lactoferrin market. Bovine milk is a readily available source of lactoferrin. The dairy industry produces a significant amount of bovine milk, allowing for a consistent and ample supply of bovine lactoferrin. In August 2022, TurtleTree, a biotech company, declared its production of LF + , the world's ﬁrst sustainable bovine lactoferrin created using precision fermentation technology.

Bovine lactoferrin shares structural and functional similarities with human lactoferrin, making it a suitable substitute in various applications. It exhibits similar immune-enhancing and antimicrobial properties, which are desirable characteristics in products that incorporate lactoferrin. These features encourage producers to supply fresh bovine lactoferrin products, which has boosted market share.

Geographical Analysis

Growing Health Consciousness in North America Regions

In 2022, the North American region had a significant share of the lactoferrin market. The region's healthcare infrastructure possesses advanced medical facilities, research institutes, and pharmaceutical companies, establishing favorable conditions for the progress, manufacturing, and dissemination of products incorporating lactoferrin.

The North American market has witnessed a growing interest in functional foods, dietary supplements, and nutraceuticals. For instance, according to the Centers for Disease Control and Prevention, in 2021, data from the National Health and Nutrition Examination Survey, showed that 57.6%of the US adults of age 20 and over, used dietary supplements. Consumers in this region are increasingly seeking products that offer health benefits beyond basic nutrition. Lactoferrin, with its potential immune-enhancing and gut health properties, aligns well with this trend, driving its demand in the market.

Competitive Landscape

The major global players include MILEI GmbH, Farbest Brands, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputa Dairy Australia Pty Ltd., Forterra Co-Operative Group, Armor Proteins, Hilmar Cheese Company, Inc., Conagen, Inc.

Why Purchase the Report?

To visualize the global lactoferrin market segmentation based on source, application, end-use, and region understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Lactoferrin market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The Global Lactoferrin Market Report Would Provide Approximately 61 Tables, 64 Figures, and 102 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Source
3.2. Snippet by Application
3.3. Snippet by End-Use
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Rising Infant Population
  - 4.1.1.2. Increased Awareness of Lactoferrin's Health Benefits
- 4.1.2. Restraints
  - 4.1.1.2. Regulatory and Intellectual Property Issues
- 4.1.3. Opportunity
  - 4.1.2.1. Rising Demand for Functional Ingredients
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Bovine Milk *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Engineered Rice
7.4. Porcine Milk
7.5. Human Milk
7.6. Murine Milk
7.7. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Immune Health*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Oral Hygiene
8.4. Gut Health
8.5. Skin Care
8.6. Others

9. By End-Use

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
- 9.1.2. Market Attractiveness Index, By End-Use
9.2. Functional Foods & Drinks*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dietary Supplements
9.4. Infant Formula
9.5. Cosmetics
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. MILEI GmbH*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Farbest Brands
12.3. Synlait Ltd.
12.4. Glanbia Plc.
12.5. Bega Bionutrients
12.6. Saputa Dairy Australia Pty Ltd.
12.7. Forterra Co-Operative Group
12.8. Armor Proteins
12.9. Hilmar Cheese Company, Inc.
12.10. Conagen, Inc.

LIST NOT EXHAUSTIVE